Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-15-006821
Filing Date
2015-08-10
Accepted
2015-08-10 16:01:12
Documents
14
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q kite-10q_20150630.htm 10-Q 1938345
2 EX-10.1 kite-ex101_196.htm EX-10.1 341698
3 EX-10.2 kite-ex102_193.htm EX-10.2 112588
4 EX-10.3 kite-ex103_166.htm EX-10.3 37480
5 EX-31.1 kite-ex311_6.htm EX-31.1 8546
6 EX-31.2 kite-ex312_7.htm EX-31.2 8538
7 EX-32.1 kite-ex321_10.htm EX-32.1 6439
8 EX-32.2 kite-ex322_12.htm EX-32.2 6571
  Complete submission text file 0001564590-15-006821.txt   9087823

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT kite-20150630.xml EX-101.INS 2057536
10 XBRL TAXONOMY EXTENSION SCHEMA kite-20150630.xsd EX-101.SCH 58363
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kite-20150630_cal.xml EX-101.CAL 51377
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kite-20150630_def.xml EX-101.DEF 202866
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE kite-20150630_lab.xml EX-101.LAB 483975
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kite-20150630_pre.xml EX-101.PRE 366139
Mailing Address 2225 COLORADO AVENUE SANTA MONICA CA 90404
Business Address 2225 COLORADO AVENUE SANTA MONICA CA 90404 (310) 824-9999
Kite Pharma, Inc. (Filer) CIK: 0001510580 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
Type: 10-Q | Act: 34 | File No.: 001-36508 | Film No.: 151040661
SIC: 2836 Biological Products, (No Diagnostic Substances)